Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00190-6/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=263719363&_hsenc=p2ANqtz-_xfAp48BIp5faPG69fSX9GvqmKZNSAfQpIEE8PAYHNWWj8Qo5qn5zXeUy71dbB5zHK-hvNQG7w8DOI7XuOTo2_mwFmLA&utm_content=263697128&utm_source=hs_email